State Of Tennessee, Treasury Department Arvinas, Inc. Transaction History

State Of Tennessee, Treasury Department

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$60.27 - $81.57 $1.55 Million - $2.1 Million	-25,774 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$65.85 - $96.21 $3.39 Million - $4.96 Million	-51,528 Reduced 66.66%	25,774 $2.12 Million
Q3 2021 Nov 12, 2021	BUY	$73.2 - $107.87 $5.66 Million - $8.34 Million	77,302 New	77,302 $6.35 Million

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

Stay updated on State Of Tennessee, Treasury Department with notifications on news.